Pilot of an mHealth-enhanced, Safer Conception Intervention to Reduce HIV-1 Risk Among Kenyan HIV-1 Serodiscordant Couples
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2018
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms SCIP
- 10 Sep 2018 Status changed from active, no longer recruiting to completed.
- 01 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Feb 2017 New trial record